Peer-reviewed veterinary case report
Dog developed heart muscle disease after epirubicin chemotherapy
By Lee, Ye-Rin et al.·Published in The Canadian veterinary journal = La revue veterinaire canadienne·2015·Department of Veterinary Internal Medicine, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Anthracycline-induced cardiomyopathy in a dog treated with epirubicin.
- Species:
- dog
Plain-English summary
An 8-year-old American cocker spaniel was diagnosed with dilated cardiomyopathy, a heart condition that can cause symptoms like weakness and difficulty breathing. This condition developed after the dog received multiple rounds of chemotherapy, including a drug called epirubicin, to treat lymphoma four years earlier. The heart issue was linked to the toxicity of the chemotherapy. Unfortunately, the dog’s heart condition is a serious side effect of the treatment received for cancer.
People also search for: dog heart problems after chemotherapy · cocker spaniel dilated cardiomyopathy · epirubicin side effects in dogs
Abstract
An 8-year-old American cocker spaniel dog was diagnosed with dilated cardiomyopathy. Four years earlier, the dog had been diagnosed with multicentric lymphoma and had received 4 cycles of multi-agent chemotherapy, including doxorubicin and epirubicin. The total cumulative dose of epirubicin was 168 mg/m(2). Dilated cardiomyopathy was considered a consequence of epirubicin toxicity.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26028676/